Thrombocytopaenia in pregnancy: the importance of differential diagnosis during the COVID-19 pandemic

Since the beginning of the COVID-19 pandemic, an optimal management of vulnerable patients, such as pregnant women, has been regarded as a challenge for healthcare professionals. Although thrombocytopaenia is considered a minor criterion for admission within an intensive care unit, a low platelet co...

Full description

Saved in:
Bibliographic Details
Published inThe journal of maternal-fetal & neonatal medicine Vol. 35; no. 12; p. 2414
Main Authors Zitiello, A, Grant, G E, Ben Ali, N, Feki, A
Format Journal Article
LanguageEnglish
Published England 18.06.2022
Subjects
COVID-19 - diagnosis
Diagnosis, Differential
Female
Humans
Intensive Care Units
Pandemics
Pregnancy
Thrombocytopenia - complications
Thrombocytopenia - diagnosis
COVID-19
Pregnancy
SARS
SARS-CoV-2
thrombocytopaenia
thromboembolism
Online AccessGet more information

Cover

More Information
Summary:Since the beginning of the COVID-19 pandemic, an optimal management of vulnerable patients, such as pregnant women, has been regarded as a challenge for healthcare professionals. Although thrombocytopaenia is considered a minor criterion for admission within an intensive care unit, a low platelet count has been observed in COVID-19 patients, including a pregnant woman, who developed severe pulmonary complications. Furthermore, thrombocytopaenia has been proposed as a potential biomarker in order to identify cases at high-risk complications. Nevertheless, thrombocytopaenia is a relatively frequent condition observed in pregnancy. In this context, a differential diagnosis is essential for the correct management of COVID-19 pregnant women.
ISSN:1476-4954
DOI:10.1080/14767058.2020.1786527